273 related articles for article (PubMed ID: 15899961)
1. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker.
Devaraj S; O'Keefe G; Jialal I
J Clin Endocrinol Metab; 2005 Aug; 90(8):4549-54. PubMed ID: 15899961
[TBL] [Abstract][Full Text] [Related]
2. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
[TBL] [Abstract][Full Text] [Related]
3. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used.
Marques-Vidal P; Velho S; Waterworth D; Waeber G; von Känel R; Vollenweider P
Eur J Clin Nutr; 2012 Apr; 66(4):426-35. PubMed ID: 21952696
[TBL] [Abstract][Full Text] [Related]
4. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes.
Castoldi G; Galimberti S; Riva C; Papagna R; Querci F; Casati M; Zerbini G; Caccianiga G; Ferrarese C; Baldoni M; Valsecchi MG; Stella A
Clin Sci (Lond); 2007 Jul; 113(2):103-8. PubMed ID: 17362204
[TBL] [Abstract][Full Text] [Related]
5. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
[TBL] [Abstract][Full Text] [Related]
6. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
Seddon JM; George S; Rosner B; Rifai N
Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
Liu T; Fang Z; Yang D; Liu Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.
Okopień B; Krysiak R; Herman ZS
J Clin Endocrinol Metab; 2006 May; 91(5):1770-8. PubMed ID: 16492702
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
10. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
[TBL] [Abstract][Full Text] [Related]
12. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
[TBL] [Abstract][Full Text] [Related]
13. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study).
Marques-Vidal P; Bastardot F; von Känel R; Paccaud F; Preisig M; Waeber G; Vollenweider P
Clin Endocrinol (Oxf); 2013 Feb; 78(2):232-41. PubMed ID: 22409372
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques.
Grufman H; Gonçalves I; Edsfeldt A; Nitulescu M; Persson A; Nilsson M; Nilsson J
J Intern Med; 2014 Feb; 275(2):127-33. PubMed ID: 24010553
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
17. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
18. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
19. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
20. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
